Guideline-directed statin therapy and cardiovascular events among patients with type 2 diabetes mellitus in South Ethiopia: a case-control study
Monaldi Archives for Chest Disease · 2026-11-11
DOI: 10.4081/monaldi.2026.4262 ↗Abstract
Type 2 diabetes mellitus (T2DM) significantly increases cardiovascular disease (CVD) risk. Statin therapy is a cornerstone of primary prevention, yet suboptimal prescribing and adherence remain common, particularly in resource-limited settings. Evidence on statin utilization and outcomes in Ethiopian T2DM patients is limited. This study aimed to determine the association between guideline-directed statin therapy and cardiovascular events among T2DM patients at Wolaita Sodo University Comprehensive Specialized Hospital (WSUCSH). A hospital-based case-control study was conducted from April to July 2022 at WSUCSH in South Ethiopia. Cases were T2DM patients aged 40-75 years who developed a first cardiovascular event after T2DM diagnosis. Controls were T2DM patients without CVD, frequency-matched by age (±5 years) and sex. Data were collected through retrospective medical record review and patient interviews using a structured data abstraction form and the Morisky Medication Adherence Scale. Unconditional logistic regression was used to estimate adjusted odds ratios (AOR) with 95% confidence intervals (CI), with age and sex included as covariates to account for the frequency-matched design. A p-value
EUVIMED